Inventor · disambiguated record
Thomas Zioncheck
Also filed as: ZIONCHECK THOMAS · ZIONCHECK THOMAS F
7 granted patents·2 pending applications·156 citations·filing 1994–2006
87Inventor score
Files withGENENTECH INC9
Top patents by PatentIndex Score
9 records- 0185US5464815AInhibition of heparin-bindingGENENTECH INC·Filed 1994·Granted Nov 7, 1995·67 cites·27 claims
- 0283US7078382B1Modulation of eNOS activity and therapeutic uses thereofGENENTECH INC·Filed 2000·Granted Jul 18, 2006·14 cites·12 claims
- 0366US7208472B2Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altered pharmacological propertiesGENENTECH INC·Filed 2002·Granted Apr 24, 2007·1 cites·7 claims
- 0466US6485942B1Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of productionGENENTECH INC·Filed 1997·Granted Nov 26, 2002·30 cites·27 claims
- 0566US5849689AMethod of extending the plasma half-life of deletion variants of hepatocyte growth factorGENENTECH INC·Filed 1995·Granted Dec 15, 1998·22 cites·23 claims
- 0654US6395707B1Methods of treatment utilizing variants of vascular endothelial cell growth factorGENENTECH INC·Filed 1997·Granted May 28, 2002·13 cites·13 claims
- 0751US2006188503A1Modulation of eNOS activity and therapeutic uses thereofGENENTECH INC·Filed 2006·Application pending·0 cites
- 0849US5851989AMethod of extending the plasma half-life of vascular endothelial cell growth factorGENENTECH INC·Filed 1995·Granted Dec 22, 1998·9 cites·14 claims
- 0949US2007203063A1Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological propertiesGENENTECH INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Zioncheck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →